Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GoodRx Holdings, Inc.GDRX · Entity 4838 | Chief Financial Officer | January 08, 2025 | January 08, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GoodRx Holdings, Inc.
Report date January 08, 2025 · Filed January 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 363,561 |
Ending reported balance
After 2025-01-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-01-08 · Exercise / conversion · Acquired 89,292 · Balance 392,596 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 2 · 2025-01-08 · Tax withholding · Disposed 29,035 · Balance 363,561 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 267,876 |
Reported balance
After 2025-01-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-01-08 · Exercise / conversion · Disposed 89,292 · Balance 267,876 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2: The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2: The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 08, 2025 Filed Jan 8, 2025 18:43 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 89,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000008 · wk-form4_1736379800.xml · derivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,876 Underlying: Class A Common Stock · 89,292 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. F2 · derivative.expiration_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. Read SEC document |
| January 08, 2025 Filed Jan 8, 2025 18:43 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 29,035 | $4.41 | $128,044.35 |
DisclosureSEC source: 0001809519-25-000008 · wk-form4_1736379800.xml · nonDerivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,561 Read SEC document |
| January 08, 2025 Filed Jan 8, 2025 18:43 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 89,292 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000008 · wk-form4_1736379800.xml · nonDerivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,596 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:39 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 54,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000208 · wk-form4_1733787554.xml · derivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378,448 Underlying: Class A Common Stock · 54,064 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:39 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 24,659 | $4.91 | $121,075.69 |
DisclosureSEC source: 0001809519-24-000208 · wk-form4_1733787554.xml · nonDerivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,304 Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:39 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 54,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000208 · wk-form4_1733787554.xml · nonDerivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 327,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 08, 2024 Filed Sep 9, 2024 19:59 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 54,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000177 · wk-form4_1725926387.xml · derivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 432,512 Underlying: Class A Common Stock · 54,064 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| September 08, 2024 Filed Sep 9, 2024 19:59 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 24,700 | $7.71 | $190,437.00 |
DisclosureSEC source: 0001809519-24-000177 · wk-form4_1725926387.xml · nonDerivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,899 Read SEC document |
| September 08, 2024 Filed Sep 9, 2024 19:59 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 54,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000177 · wk-form4_1725926387.xml · nonDerivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 298,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 08, 2024 Filed Jun 10, 2024 18:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 54,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000106 · wk-form4_1718060284.xml · derivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 486,576 Underlying: Class A Common Stock · 54,064 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| June 08, 2024 Filed Jun 10, 2024 18:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 21,481 | $8.55 | $183,662.55 |
DisclosureSEC source: 0001809519-24-000106 · wk-form4_1718060284.xml · nonDerivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,535 Read SEC document |
| June 08, 2024 Filed Jun 10, 2024 18:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 54,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000106 · wk-form4_1718060284.xml · nonDerivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 266,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 17:12 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantStock Option (Right to Buy) · Derivative | 515,793 | $0.00 Strike: $7.22 | $0.00 |
DisclosureSEC source: 0001809519-24-000049 · wk-form4_1710450723.xml · derivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 515,793 Underlying: Class A Common Stock · 515,793 shares Expires 2034-03-12 F3 · derivative.exercise_date: The option will vest and become exercisable as to 25% of the underlying shares on January 8, 2025 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 17:12 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantRestricted Stock Unit · Derivative | 357,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000049 · wk-form4_1710450723.xml · derivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 357,168 Underlying: Class A Common Stock · 357,168 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. F2 · derivative.expiration_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. Read SEC document |
| March 08, 2024 Filed Mar 8, 2024 17:14 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 54,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000043 · wk-form4_1709936058.xml · derivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 540,640 Underlying: Class A Common Stock · 54,064 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| March 08, 2024 Filed Mar 8, 2024 17:14 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 17,240 | $7.54 | $129,989.60 |
DisclosureSEC source: 0001809519-24-000043 · wk-form4_1709936058.xml · nonDerivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,952 Read SEC document |
| March 08, 2024 Filed Mar 8, 2024 17:14 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 54,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000043 · wk-form4_1709936058.xml · nonDerivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 17:18 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 54,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000057 · wk-form4_1702073926.xml · derivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 594,704 Underlying: Class A Common Stock · 54,064 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 17:18 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 24,757 | $5.94 | $147,056.58 |
DisclosureSEC source: 0001809519-23-000057 · wk-form4_1702073926.xml · nonDerivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,128 Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 17:18 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 54,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000057 · wk-form4_1702073926.xml · nonDerivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 08, 2023 Filed Sep 8, 2023 17:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 54,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000008 · wk-form4_1694208351.xml · derivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 648,768 Underlying: Class A Common Stock · 54,064 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| September 08, 2023 Filed Sep 8, 2023 17:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 19,757 | $6.16 | $121,703.12 |
DisclosureSEC source: 0001809519-23-000008 · wk-form4_1694208351.xml · nonDerivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,821 Read SEC document |
| September 08, 2023 Filed Sep 8, 2023 17:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 54,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-23-000008 · wk-form4_1694208351.xml · nonDerivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 21:33 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Units · Derivative | 54,064 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-027562 · ownership.xml · derivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 702,832 Underlying: Class A Common Stock · 54,064 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 21:33 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 16,611 | $5.41 | $89,865.51 |
DisclosureSEC source: 0000950170-23-027562 · ownership.xml · nonDerivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,514 Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 21:33 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 54,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-027562 · ownership.xml · nonDerivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 19:59 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 54,064 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007790 · doc4.xml · derivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756,896 Underlying: Class A Common Stock · 54,064 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 19:59 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 17,397 | $5.50 | $95,683.50 |
DisclosureSEC source: 0000899243-23-007790 · doc4.xml · nonDerivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,061 Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 19:59 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 54,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-007790 · doc4.xml · nonDerivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 17:24 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 54,063 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-038253 · doc4.xml · derivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 810,960 Underlying: Class A Common Stock · 54,063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% to vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% to vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 17:24 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 16,669 | $4.98 | $83,011.62 |
DisclosureSEC source: 0000899243-22-038253 · doc4.xml · nonDerivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,394 Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 17:24 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 54,063 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-038253 · doc4.xml · nonDerivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 16:47 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantRestricted Stock Unit · Derivative | 865,023 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-032043 · doc4.xml · derivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865,023 Underlying: Class A Common Stock · 865,023 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vests as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% to vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vests as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% to vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 16:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0000899243-21-050104 · doc4.xml · derivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,500 Underlying: Class A Common Stock · 12,500 shares Expires 2030-03-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on March 2, 2020. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 16:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 12,500 | $33.05 | $413,182.50 |
DisclosureSEC source: 0000899243-21-050104 · doc4.xml · nonDerivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020, as amended on August 27, 2021. F2 · price: This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.31. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 16:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 12,500 | $6.84 | $85,500.00 |
DisclosureSEC source: 0000899243-21-050104 · doc4.xml · nonDerivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 16:22 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0000899243-21-046781 · doc4.xml · derivative · entry 5 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,000 Underlying: Class A Common Stock · 12,500 shares Expires 2030-03-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on March 2, 2020. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 16:22 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 6,111 | $40.22 | $245,783.20 |
DisclosureSEC source: 0000899243-21-046781 · doc4.xml · nonDerivative · entry 4 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020, as amended on August 27, 2021. F4 · price: This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.91 to $40.55. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 16:22 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 2,200 | $39.31 | $86,474.96 |
DisclosureSEC source: 0000899243-21-046781 · doc4.xml · nonDerivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,111 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020, as amended on August 27, 2021. F3 · price: This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.86 to $39.81. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 16:22 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 4,189 | $38.35 | $160,646.47 |
DisclosureSEC source: 0000899243-21-046781 · doc4.xml · nonDerivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,311 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020, as amended on August 27, 2021. F2 · price: This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.82 to $38.80. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 16:22 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 12,500 | $6.84 | $85,500.00 |
DisclosureSEC source: 0000899243-21-046781 · doc4.xml · nonDerivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:32 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0000899243-21-042900 · doc4.xml · derivative · entry 4 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,500 Underlying: Class A Common Stock · 12,500 shares Expires 2030-03-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on March 2, 2020. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:32 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-042900 · doc4.xml · nonDerivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020, as amended on August 27, 2021 Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:32 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 12,300 | $44.04 | $541,660.02 |
DisclosureSEC source: 0000899243-21-042900 · doc4.xml · nonDerivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020, as amended on August 27, 2021 F2 · price: This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.66 to $44.61. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:32 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 12,500 | $6.84 | $85,500.00 |
DisclosureSEC source: 0000899243-21-042900 · doc4.xml · nonDerivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 21:13 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0000899243-21-038251 · doc4.xml · derivative · entry 4 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,000 Underlying: Class A Common Stock · 7,500 shares Expires 2030-03-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on March 2, 2020. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 21:13 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 500 | $41.52 | $20,758.00 |
DisclosureSEC source: 0000899243-21-038251 · doc4.xml · nonDerivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020, as amended on August 27, 2021. F3 · price: This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.99 to $41.96. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 21:13 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 7,000 | $40.22 | $281,538.60 |
DisclosureSEC source: 0000899243-21-038251 · doc4.xml · nonDerivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020, as amended on August 27, 2021. F2 · price: This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.87 to $40.70. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 21:13 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 7,500 | $6.84 | $51,300.00 |
DisclosureSEC source: 0000899243-21-038251 · doc4.xml · nonDerivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 16:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0000899243-21-034726 · doc4.xml · derivative · entry 4 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,500 Underlying: Class A Common Stock · 12,500 shares Expires 2030-03-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on March 2, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.